Peginesatide
Alternative Names: AF 37702; EPO mimetic - Affymax; Erythropoetin mimetic - Affymax; Hematide; Omontys; Peginesatide acetateLatest Information Update: 05 Nov 2023
At a glance
- Originator Affymax
- Developer Affymax; Takeda
- Class Antianaemics; Peptides; Polyethylene glycols
- Mechanism of Action Erythropoietin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Market Withdrawal Anaemia
- Discontinued Aplastic anaemia; Chemotherapy-induced anaemia
Most Recent Events
- 30 Oct 2014 Discontinued - Phase-II for Anaemia in Europe (SC)
- 30 Oct 2014 Discontinued - Phase-II for Anaemia in Russia (Parenteral)
- 30 Oct 2014 Discontinued - Phase-II for Aplastic anaemia in France, Germany and United Kingdom (SC)